The safety of in-hospital initiation of SGLT2 inhibitor with MRA therapy in patients hospitalized for heart failure with a reduced left ventricular ejection fraction and chronic kidney disease
1 September 2024 (10:00 - 10:40)
Organised by: 
About the speaker
National Pirogov Memorial Medical University, Vinnitsa (Ukraine)
5 More presentations in this session
Mr A. Hacil (Paris, FR)
Professor O. Hanon (Paris, FR)
Miss L. Souza (Botucatu, BR)
Access the full session
The Event
ESC Congress 2024
1 September 2024
10:00 CET
You may be interested in
Congress Session
